Welcome to LookChem.com Sign In|Join Free
  • or
3,4'-DIMETHOXY-3',5,7-TRIHYDROXYFLAVONE, also known as a dimethoxyflavone derivative of quercetin, is a naturally occurring flavonoid compound. It is characterized by the presence of two methoxy groups at the 3 and 4' positions, along with three hydroxyl groups at the 3', 5, and 7 positions. 3,4'-DIMETHOXY-3',5,7-TRIHYDROXYFLAVONE has been isolated from the plant Combretum quadrangulare and has demonstrated significant antineoplastic (anti-cancer) activity.

33429-83-3

Post Buying Request

33429-83-3 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

33429-83-3 Usage

Uses

Used in Pharmaceutical Industry:
3,4'-DIMETHOXY-3',5,7-TRIHYDROXYFLAVONE is used as an antineoplastic agent for its potential cancer-fighting properties. 3,4'-DIMETHOXY-3',5,7-TRIHYDROXYFLAVONE has shown to exhibit antineoplastic activity, making it a promising candidate for the development of novel cancer treatments and therapies.
Used in Cancer Research:
3,4'-DIMETHOXY-3',5,7-TRIHYDROXYFLAVONE is used as a research compound for studying its antineoplastic effects and understanding its mechanism of action. This knowledge can contribute to the development of new cancer therapies and the improvement of existing ones.
Used in Natural Product Chemistry:
3,4'-DIMETHOXY-3',5,7-TRIHYDROXYFLAVONE is used as a starting material or a key intermediate in the synthesis of other bioactive compounds with potential applications in various fields, including pharmaceuticals, cosmetics, and agriculture.

Check Digit Verification of cas no

The CAS Registry Mumber 33429-83-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,3,4,2 and 9 respectively; the second part has 2 digits, 8 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 33429-83:
(7*3)+(6*3)+(5*4)+(4*2)+(3*9)+(2*8)+(1*3)=113
113 % 10 = 3
So 33429-83-3 is a valid CAS Registry Number.

33429-83-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name 5,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)-3-methoxychromen-4-one

1.2 Other means of identification

Product number -
Other names 5,7,3'-Trihydroxy-3,4'-dimethoxyflavone

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:33429-83-3 SDS

33429-83-3Relevant academic research and scientific papers

Quercetin analogs with high fetal hemoglobin-inducing activity

Pabuprapap, Wachirachai,Wassanatip, Yanisa,Khetkam, Pichit,Chaichompoo, Waraluck,Kunkaewom, Sukanya,Senabud, Pongpan,Hata, Janejira,Chokchaisiri, Ratchanaporn,Svasti, Saovaros,Suksamrarn, Apichart

, p. 1755 - 1765 (2019/08/02)

β-Thalassemia is the major health problems in developing countries, when affected patients and healthy carriers are numerous, resulting a total absence or severe decrease in the production of β-globin chains. The use of chemical agents for increasing the production of fetal hemoglobin (HbF) by reactivating γ-globin gene to balance excess α-globin chains is an alternative therapeutic approach. Therefore, the search for molecules exhibiting the property of inducing γ-globin gene expression is of great interest. In this report, we discovered that quercetin (1), the major flavonoid isolated from the heartwoods of the medicinal plant Anaxagorea luzonensis promoted the expression of γ-globin gene. Chemical modification of 1 to fourteen methyl ether analogs (2?15) was conducted. The structures of these compounds were established on the basis of their spectroscopic data and by comparison with those of the reported values. The parent flavonoid and its chemically modified analogs were investigated for their γ-globin gene induction for the first time. The parent compound 1 exhibited less induced γ-globin gene expression than cisplatin and hemin, the positive controls. 3,4′-Di-O-methylquercetin (7), the modified analog, significantly enhanced γ-globin gene expression with 2.6-fold change at 8 μM, which was slightly higher than cisplatin and hemin. Moreover, compounds 1 and 7 displayed less cytotoxic activity against K562::ΔGγAγEGFP cells than cisplatin. Structure-activity relationship (SAR) study revealed that the methoxyl groups at the 3- and 4?-positions and the free hydroxyl group at the 7-position are required for strong HbF-inducing activity.

Synthesized quercetin derivatives stimulate melanogenesis in B16 melanoma cells by influencing the expression of melanin biosynthesis proteins MITF and p38 MAPK

Yamauchi, Kosei,Mitsunaga, Tohru,Inagaki, Mizuho,Suzuki, Tohru

, p. 3331 - 3340 (2014/06/23)

In order to understand the effect of structure-activity relationships on melanogenesis using B16 melanoma cells, 19 quercetin derivatives were synthesized. Among the synthesized compounds, 3-O-methylquercetin (11) and 3′,4′,7-O-trimethylquercetin (14) increased melanin content more potently than the positive control theophylline, while exhibiting low cytotoxicity. Compound 11 exhibited less melanogenesis-stimulating activity than compound 14. However, 11 increased the expression of tyrosinase and tyrosinase-related protein 1 (TRP-1) to a greater extent than 14, thereby suggesting that melanogenesis in melanoma cells does not depend solely on the expression of the enzymes catalyzing melanin biosynthesis. Furthermore, 14 also stimulated the expression of the microphthalmia-associated transcription factor (MITF) and p-p38 mitogen activated protein kinase (MAPK), while they were not increased by 11. These results suggest that 11 may enhance the expression of tyrosinase and TRP-1 by regulating the proteasomal degradation of melanogenic enzymes and/or by activating other transcriptional factors regulating enzyme expression.

Hemisynthesis of all the O-monomethylated analogues of quercetin including the major metabolites, through selective protection of phenolic functions

Bouktaib, Mohamed,Lebrun, Stéphane,Atmani, Aziz,Rolando, Christian

, p. 10001 - 10009 (2007/10/03)

A new methodology for the hemisynthesis of all the five O-monomethylated analogues of quercetin (3′-O-methylquercetin (isorhamnetin), 4′-O-methylquercetin (tamarixetin), 3-O-methylquercetin, 5-O-methylquercetin (azaleatin) and 7-O-methylquercetin (rhamnetin)) through sequential protection of the different phenolic functions of quercetin is reported.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 33429-83-3